A curated selection of the top stories and editor’s picks from the DocWire News Cardiology section over the last week.
The full results of the ODYSSEY OUTCOMES study, looking at PCSK9 inhibitor alirocumab for the reduction of second heart attack risk in patients who had survived a first heart attack.
A new analysis suggesting increased risk for heart failure, stroke and other adverse outcomes in people under the age of 40 who have various stages of hypertension.
New evidence suggests that a low-sodium diet may have no effect on the risk for heart failure.
Several medications used to treat hypertension may also lower the risk for Alzheimer’s disease (AD) in certain patients, according to a new retrospective cohort study.
DocWire News Cardiology Abstracts You May Have Missed
High-Intensity Versus Non-High-Intensity Statins in Patients Achieving Low-Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention (Journal of the American Heart Association)